Alira Health

Alira Health

Content of Integrated Summaries of Efficacy and Safety (ISE/ISS): A Blog Series

We are pleased to bring you a new series on the Content of the Integrated Summaries of Efficacy and Safety.

This blog series on the Content of ISE/ISS focuses on the structure of the common technical document (CTD) and the objectives of the ISE/ISS. These articles outline what elements are required and the specific requirements in FDA submissions.

Articles
Published on:
June 6, 2023

Introduction to the Integrated Summaries of Efficacy and Safety (ISE/ISS)

When sponsors prepare an application for the registration of pharmaceuticals for human use, a common technical document (CTD), with organization and content driven by the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) Guidelines, must be submitted to the regulatory authorities to facilitate the review process. This article focuses on the structure of the common CTD and the objectives of the ISE/ISS.

Read Now


Content of the Integrated Summaries of Efficacy and Safety (ISE/ISS)

The Integrated Summaries of Efficacy (Effectiveness) and Safety (ISE/ISS) are highly technical documents included in the common technical document (CTD) which sponsors must submit to regulatory authorities as part of the application for the registration of pharmaceuticals for human use. This article focuses on what elements are required in the ISE/ISS to ensure a successful submission.

Read Now


Specific Requirements for Integrated Summaries of Efficacy and Safety(ISE/ISS) in FDA Submissions

This article focuses on specific requirements for ISE/ISS FDA submissions and other specific requirements.

Read Now

ISE/ISS Blog series


Get Help Navigating the Complexity of ISE/ISS

Work with our experts to put together your ISE/ISS package and successfully defend it in front of authorities. Benefit from our team’s decades of experience in navigating the complexity of ISE/ISS.

Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.